This led us to hypothesize that vitamin D treatment alone and/or in combination with LDHA inhibitors [49] might be a therapeutic strategy in breast cancer, acting on both cancer and stromal cells to potentiate the chemotherapeutic response in breast tumors. This evidence concerns the gene LDHA and cancer.